Re: HoLEP: The New Gold Standard for Surgical Treatment of Benign Prostatic Hyperplasia Editorial Comment

被引：0
|
作者：
Kaplan, Steven
机构：
来源：
JOURNAL OF UROLOGY | 2022年 / 207卷 / 05期
关键词：
D O I：
10.1097/JU.0000000000002467
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
This article reviews the epidemiology of benign prostatic hyperplasia (BPH), evaluation of patients with lower urinary tract symptomatology (LUTS), and management of patients with BPH and LUTS. The evaluation includes history and physical examination, laboratory testing, and specialized studies. The management includes medical and surgical options. Medical options include alpha-1-adrenergic receptor blockers, 5alpha-reductase inhibitors, and combinations of these and other medications. Surgical options include endoscopic procedures, open procedures, and laser procedures.
引用
收藏
页码：1127 / 1127
页数：1
相关论文
共 50 条
  • [21] Re: Vitamin D Deficiency as a Potential Marker of Benign Prostatic Hyperplasia Editorial Comment
    Kaplan, Steven A.
    [J]. JOURNAL OF UROLOGY, 2018, 200 (05): : 919 - 920
  • [22] Re: Benign Prostatic Hyperplasia Related Content on YouTube: Unregulated and Concerning Editorial Comment
    Kaplan, Steven A.
    [J]. JOURNAL OF UROLOGY, 2016, 195 (04): : 1043 - 1044
  • [23] Use of low-powered HoLEP for the treatment of benign prostatic hyperplasia
    Gilling, P.
    Mason, C.
    Reuther, R.
    Van Rij, S.
    Fraundorfer, M.
    [J]. BJU INTERNATIONAL, 2013, 111 : 13 - 13
  • [24] Re: Tamsulosin and the Risk of Dementia in Older Men with Benign Prostatic Hyperplasia Editorial Comment
    Kaplan, Steven A.
    [J]. JOURNAL OF UROLOGY, 2019, 201 (01): : 4 - 4
  • [25] Re: Association of Physician Specialty and Medical Therapy for Benign Prostatic Hyperplasia Editorial Comment
    Kaplan, Steven A.
    [J]. JOURNAL OF UROLOGY, 2014, 192 (04): : 1165 - 1166
  • [26] Re: The Prognostic Use of Inflammation and Tissue Necrosis in Benign Prostatic Hyperplasia Editorial Comment
    Kaplan, Steven A.
    [J]. JOURNAL OF UROLOGY, 2014, 192 (06): : 1768 - 1768
  • [27] Comparing the use of AquaBeam® and HoLEP for the treatment of patients with benign prostatic hyperplasia
    Toribio-Vazquez, C.
    Cansino, R.
    Fernandez-Pascual, E.
    Eguibar, A.
    Ayllon, H.
    Solano-Heranz, P.
    Perez-Carral, J. R.
    Mainez, J. A.
    Giron, M.
    Rodriguez, A.
    Yebes, A.
    Alonso, M.
    Martinez, S.
    Martinez-Pineiro, L.
    [J]. EUROPEAN UROLOGY, 2023, 83
  • [28] Editorial Comment on "Initial outcomes and surgical techniques of prostatic urethral lift for benign prostatic hyperplasia in Japan"
    Yagisawa, Takafumi
    Takagi, Toshio
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2024, 31 (07) : 762 - 763
  • [29] Re: National Trends in Surgical Therapy for Benign Prostatic Hyperplasia in the United States (2000-2008) Editorial Comment
    Malaeb, B. S.
    Yu, X.
    McBean, A. M.
    Elliott, S. P.
    [J]. JOURNAL OF UROLOGY, 2013, 189 (02): : 616 - 617
  • [30] Differential Adoption of Laser Prostatectomy for Treatment of Benign Prostatic Hyperplasia EDITORIAL COMMENT
    Humphreys, Mitchell R.
    [J]. UROLOGY, 2013, 81 (06) : 1182 - 1183
12345